AP Exam 4 part VIII Flashcards
anesthetic management of hypertrophic cardiomyopathy (long QT syndrome) to avoid sudden cardiac arrest
- BB to keep HR <130 2. avoid agents that prolong QT 3. magnesium or temp pacing if torsades occurs
_________ Is the most common CV complication after non-cardiac surgery
MI
most MIs occur within _________ hours of surgery and most are asymptomatic
48
independent predictors or perioperative MI
- increase in baseline HR for every 10b/min 2. hx of stroke (CVA) 3. major vascular surgery 4. CKD (Cr > 2.0 preop) 5. advanced age 6. emergency or urgent surgery 7. serious bleeding/transfusion >/= 2 UPRBC
airway mortality occurs because of failure to ____________, not ______________
ventilate; intubate
avoiding airway related morbidity and mortality
have airway plan A, B, C
airway M&M with supraglottic airway (LMA) is related to
- inadequate seal 2. laryngospasm 3. aspiration of gastric contents
what is the gold standard for anticpated difficult airway
fiberoptic bronchoscope with spontaneous ventilation (Video laryngoscopy emerging as alternative)
primary morbidity (adverse events) with ET intubation
- dental trauma (50%) 2. sore throat/hoarseness (40%) 3. injury to lips, tongue, oropharynx, vocal cords, & trachea
cases that are high risk for awareness under anesthesia
- trauma 2. OB 3. Cardiothoracic
episodes of awareness under anesthesia most often occur during what stage of anesthesia?
maintenance
what are some indications the patient may be experiencing awareness under anesthesia
- patient movement 2. tachycardia 3. htn
awareness under anesthesia is associated with postoperative ____________ and sequelae
PTSD
what are some postoperative sequalae related to PTSD 2/2 awareness under anesthesia
- sleep disturbances 2. nightmares 3. fear of future anesthesia 4. daytime anxiety
RF for awareness under anesthesia
- female 2. younger adults 3. obesity 4. clinician experience 5. pt hx of previous awareness 6. after duty hours or emergency procedures 7. type of surgery: Trauma, OB, CT 8. use of neuromuscular blocking agents